Johnson & Johnson

Juvenile myasthenia gravis: Inside one adolescent’s journey

29 Oct 2025

Learn more about one patient's experience with juvenile myasthenia gravis and how Johnson and Johnson is working to improve myasthenia gravis treatment.

5 ways Johnson & Johnson is innovating in medicines and therapies

28 Oct 2025

Learn more about how J&J is working to create new therapies for inflammatory bowel disease, lung cancer, depression, bladder cancer, myasthenia gravis and more.

What you need to know about Johnson & Johnson’s 2025 third-quarter earnings

14 Oct 2025

See an infographic breakdown of the Johnson & Johnson earnings report for the third quarter of 2025, including key highlights from its Innovative Medicine and MedTech businesses.

How Johnson & Johnson is helping healthcare providers remotely monitor and support patient health

09 Oct 2025

Learn how J&J's advancements in Remote Patient Monitoring and AI are potentially improving treatment for patients and clinical trials.

“Patients are the center of everything": Meet the scientist leader dedicated to developing effective IBD treatments

03 Oct 2025

Learn how Dr. Esi Lamousé leads the way in innovative IBD treatments, putting patients first in the fight against inflammatory bowel disease.

How Johnson & Johnson is advancing the fight against Alzheimer’s disease

21 Aug 2025

Learn how J&J is advancing Alzheimer’s disease research with innovative therapies, early detection and data-driven treatments.

What is inflammation?

14 Aug 2025

Inflammation is the body’s natural response to injury or infection. Learn about chronic inflammation, its causes, symptoms and J&J’s treatment innovations.

What you need to know about Johnson & Johnson’s 2025 second-quarter earnings

16 Jul 2025

See an infographic breakdown of the company’s second-quarter earnings results, including key highlights from its Innovative Medicine and MedTech businesses.

The Red Couch on the Road

10 Jul 2025

Follow The Red Couch on the Road, a video series from Johnson & Johnson that reveals the people and ideas reshaping the future of care.

Introducing the first and only daily disposable multifocal contact lens for people with astigmatism

25 Jun 2025

Discover Acuvue® Oasys Max 1-Day, the first daily multifocal toric contact lens for astigmatism—clear vision, comfort and blue light filtering.

View details about the software product Informachine News Trackers